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Abstract
Next Generation Sequencing (NGS) methods are driving profound changes in biomedical
research, with a growing impact on patient care. Many academic medical centers are evalu-
ating potential models to prepare for the rapid increase in NGS information needs. This
study sought to investigate (1) how and where sequencing data is generated and analyzed,
(2) research objectives and goals for NGS, (3) workforce capacity and unmet needs, (4)
storage capacity and unmet needs, (5) available and anticipated funding resources, and (6)
future challenges. As a precursor to informed decision making at our institution, we under-
took a systematic needs assessment of investigators using survey methods. We recruited
331 investigators from over 60 departments and divisions at the University of Pittsburgh
Schools of Health Sciences and had 140 respondents, or a 42% response rate. Results
suggest that both sequencing and analysis bottlenecks currently exist. Significant educa-
tional needs were identified, including both investigator-focused needs, such as selection of
NGS methods suitable for specific research objectives, and program-focused needs, such
as support for training an analytic workforce. The absence of centralized infrastructure was
identified as an important institutional gap. Key principles for organizations managing this
change were formulated based on the survey responses. This needs assessment provides
an in-depth case study which may be useful to other academic medical centers as they
identify and plan for future needs.
Introduction
Next generation sequencing (NGS), with its high-throughput and range of applications, is
revolutionizing life science research. NGS techniques are being used in research as diverse as
the study of the microbiome [1], complexity of alternative splicing [2], and the mutational
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landscape in cancer [3]. NGS technologies are also beginning to impact the practice of medi-
cine through the use of disease-targeted clinical sequencing [4], for example in cancer treat-
ment selection [5, 6]. With further research, a more personalized, precise, and predictive model
for medicine may be possible [7]. However, wider adoption of high throughput technology
could also significantly stress academic medical centers, which are already burdened by
decreased resources. To better understand what institutional resources are most important to
support research communities that are adopting these technologies, we developed and admin-
istered an NGS needs assessment survey to a large number of biomedical researchers at a single
university associated with an academic medical center (AMC).
Background
Next generation sequencing techniques developed rapidly after the publication of the first draft
of the human genome, with the introduction of massively parallel sequencing (MPS) technol-
ogy in 2005 [8]. Parallelization of NGS technologies provided a faster, higher-throughput and
lower cost method for sequencing than the traditional Sanger dideoxynucleotide sequencing
method [9]. The cost of generating a whole human genome sequence reflected these advances:
the cost has plummeted from the estimated price of $2.7 billion for the first genome draft
sequence in 2001 to commercial sequencing costs of approximately $1,000 dollars for an entire
genome in 2014 [10].
There are now a number of competing NGS platforms, including Complete Genomics, Illu-
mina HiSeq, Life Technologies SOLiD and Ion Torrent, Pacific Biosciences SMRT, and Roche
454 [8, 11]. These platforms differ in sequencing chemistry, PCR amplification methods, read
lengths, types of errors, overall error rates, and methods for downstream bioinformatics analy-
sis [12]. Examples of specialized applications include whole genome sequencing (WGS) [13],
whole exome sequencing (WES) [14], RNA-Seq [15], ChIP-Seq [16], chromatin conformation
(Hi-C) [17], and Methyl-Seq [18], each with its own sophisticated data analysis pipeline. For
researchers unfamiliar with these myriad technologies and applications, choosing the appropri-
ate platform for a particular research question may appear to be a daunting challenge. The
choice of platform is often determined by cost, institutional resources for sequencing, data
management, storage, and bioinformatics capabilities. Our survey questions were designed to
understand researchers’ levels of familiarity with these emerging technologies. Additionally,
the questions sought to determine researchers’ current use of institutional versus external
resources for each step of the sequencing pipeline.
Regardless of platform or application, NGS experiments generate large amounts of data–so
called ‘Big Data’ [19, 20]–posing both data management and data analysis challenges. A single
human whole genome sequence can generate 100–250 GB of data; therefore, even small
research projects can quickly exceed the data storage capacity of individual labs [21]. It can be
challenging for researchers to evaluate and implement the wide variety of storage solutions,
each with various benefits and drawbacks. Cloud based storage and analysis solutions offer the
benefits of no startup fees, relatively inexpensive long term storage, elasticity, and relatively
rapid data access [22–25]. In comparison, keeping data locally in hard drives or storage arrays
requires a one-time cost, provides vastly quicker data access, offers more direct control over
security risks, and may have fewer regulatory complexities when compared to cloud based
approaches [26]. From a budgetary perspective, all of these storage solutions are significantly
more expensive than anything previously encountered in life science research. The NGS survey
questions were designed to discern researchers’ familiarity with storage issues, including bud-
getary considerations, in order to guide future recommendations for institution-wide NGS
infrastructure in networking and storage.
NGS Needs Assessment
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Data is considered the fourth paradigm for science, the first three being experimental, theo-
retical, and computational science [27]. NGS data offers unprecedented detail; however, the
current rate of NGS data generation outpaces the rate at which we are able to analyze it. The
complexity of NGS data analysis requires specialized interdisciplinary skills in biology, com-
puting, information technology, and statistics [28, 29]. For example, a typical RNA Seq experi-
ment analysis pipeline (alignment of reads to the reference genome, transcript quantification,
and differential expression [30]) requires all of the above-mentioned skills. With the predicted
increase in demand for data analysts and the lack of personnel with bioinformatics skills, NGS
data analysis could become a significant bottleneck in biomedical research. Through this study,
we also sought to understand the scope of the data analysis challenge, including researchers’
familiarity with computing resources such as cluster computing and whether individual inves-
tigators either have bioinformatics personnel in their laboratories or alternative solutions to
meet their analysis needs.
Materials and Methods
Setting
University of Pittsburgh Health Sciences (UPHS) encompasses the Schools of Medicine, Public
Health, Nursing, Dental medicine, Health and Rehabilitation, and Pharmacy, and is closely
affiliated with UPMC, the single largest health care provider in western Pennsylvania. More
than 2,000 individual researchers are included among the health science faculty. University of
Pittsburgh is currently ranked number 5 in NIH funding. The Institute of Personalized Medi-
cine was established in 2013 by University of Pittsburgh and UPMC to apply new knowledge
in genetics, genomics, and other fields to advance evidence-based medicine.
Survey Instrument
We developed an online survey instrument to elicit current and anticipated needs from
researchers using Next Generation Sequencing (NGS) methods and data. Initial survey ques-
tions identified investigators who were currently using, planning on using, or not planning to
use high throughput sequencing methods and to analyze resulting data. Investigators then
responded to a set of survey questions specific to each of these three groups. Questions sought
to elicit the following information: (1) how and where sequencing data is generated and ana-
lyzed, (2) research objectives and goals for NGS, (3) workforce capacity and unmet needs, (4)
storage capacity and unmet needs, (5) available and anticipated funding resources, and (6)
future challenges. Question types included multiple choice, Likert scale, ranking, rating scale,
and fill-in-the-blank responses. Each participant answered a varying number of questions
based on prior responses, ranging from a minimum of 9 and a maximum of 52 questions. The
survey was created and administered on Survey Monkey.
Recruitment
Participants were identified using searches performed on NIH RePORTER, PubMed, Univer-
sity of Pittsburgh Digital Vita research profiles, and University of Pittsburgh Schools of Health
Sciences departmental websites. RePORTER and PubMed searches were specific to University
of Pittsburgh and included one query specific to next generation sequencing, and another
more broadly termed for genetic data. Institutional profile searches included terms relevant to
sequencing and next generation sequencing. We also included faculty from departmental web-
sites with stated interests in human genetics, human genomics, or sequencing. The final list
was vetted by university scientific leaders to identify any investigators working in this area who
NGS Needs Assessment
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were not already included. For each unique participant, we collected contact information, as
well as School and Department or Division from the university directory.
Participants
We invited participation of 331 investigators from over 60 departments and divisions at the
University of Pittsburgh Schools of Health Sciences and at the Pittsburgh Supercomputing
Center. Investigators were recruited by email invitation from institutional leaders containing a
link to the survey. After the initial email, one subsequent reminder was mailed. A total of 140
respondents participated in the survey, a response rate of 42%. The research was approved as
an Exempt study by the University of Pittsburgh IRB (PRO12110213). No consent was
obtained. An informational script was used to (1) explain the purpose of the study, (2) describe
how the data would be anonymized and protected, and (3) indicate that participants were free
to withdraw at any time. The University of Pittsburgh IRB approved this procedure.
Results
Results are grouped by whether researchers are currently using NGS, will use NGS in the
future, or are not using or planning to use NGS data, depending on answers to initial survey
questions (Table 1). The All Users group, representing 79% of the respondents, includes the
55% of investigators who are currently using NGS data (Current Users) as well as the 24% who
are planning to use NGS data in the next 2 years (Future Users). The Non Users group, repre-
senting the other 21% of respondents, includes investigators who are neither currently using
these methods, nor planning to use them in the next 2 years. For each group, the total number
of respondents to any question may vary based on responses to prior questions. The reader is
referred to supplemental material for a full listing of survey questions (S1 File) and for raw
data (S2 File).
How and where NGS data are being generated
Among Current Users, 43% are currently performing high throughput sequencing within the
institution. Most of these respondents indicated that they used a core facility at their institution
(58%) or a university collaborator’s lab (45%). Only 13% of researchers who are sequencing
used an NG sequencer within their own laboratory. Among the 57% of Current Users who are
not performing high throughput sequencing in the institution, 52% expect to be sequencing
samples at the institution during the next two years. Eighty-two percent of these respondents
expect to use a core facility at the university. In comparison, 77% of Future Users expect to
begin sequencing within the institution during the next two years, and 94% of these respon-
dents expect to use a core facility.
More than half of Current Users (56%) are outsourcing sequencing of samples to an exter-
nal, non-university facility. Among these investigators, 45% are also sequencing within the uni-
versity, while 55% are not performing any high-throughput sequencing within the university.
Table 1. Number of respondents by use of NGS.
Label Description n (%)
All Users Currently using NGS data OR plan to in next 2 years 111/140 (79%)
Current Users Currently using NGS data 77/140 (55%)
Future Users Not currently using NGS data but plan to in next 2 years 34/140 (24%)
Non Users Not currently using NGS data and don’t plan to in next 2 years 29/140 (21%)
doi:10.1371/journal.pone.0131166.t001
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Sixty percent of these respondents have sent samples to another academic institution for
sequencing, and 43% have sent samples to a commercial sequencing service. Thirty-one per-
cent of Current Users who are not yet outsourcing samples for sequencing expect to begin out-
sourcing in the next two years, with 50% of respondents planning to utilize academic
institutions and 50% expecting to use commercial services.
Where and how NGS data are being analyzed
Although the majority of the respondents did not sequence data at their laboratories, 61% of
Current Users are analyzing NGS data within their own laboratory. Among investigators ana-
lyzing NGS data within their own lab, 45% are using both primary sequence and processed
data, while 31% of respondents only use primary sequence data and 24% only use processed
data. Additionally, 71% of the Current Users are running an NGS analysis pipeline in their own
laboratory. Among investigators not analyzing NGS data within their own laboratory, 52%
plan to send data to a collaborator for analysis. However, 50% of Future Users do not have any
identified plans for analysis of NGS data.
Forty-six percent of Current Users are analyzing data from publicly available NGS datasets,
with NCI’s The Cancer Genome Atlas (TCGA) being the most common dataset used (Table 2).
Respondents reported that they used 13 different public NGS datasets, and 19% reported that
they used multiple public datasets.
Investigators in the All Users group have samples ready to sequence that they have been
unable to sequence, including 33% of Current Users and 24% of Future Users (Table 3). The most
commonly cited obstacle to sequencing samples is cost, which 65% of respondents identified as a
challenge. The second greatest obstacle, identified by 23% of respondents, is limited institutional
resources. Additionally, across All Users, 31% of investigators have NGS sequencing data ready to
analyze, but have been unable to do so. Among all the reasons investigators cited, lack of exper-
tise and time are the main obstacles reported that have prevented them from analyzing data.
Research objectives and applications/platforms
Researchers use NGS to meet a wide variety of research objectives (Table 4). From a domain
perspective, 37% of All Users had cancer-related disease specific research objectives, and 39%
had non-cancer specific disease research objectives. Less common objectives included using
NGS for population biology, evolutionary biology, and metagenomics. From a task perspective,
analysis of gene expression was the most frequently cited objective (54%), followed by systems
modeling and prediction (22%), and discovery of novel transcripts (21%). Fewer than 20% of
respondents had other objectives, such as protein-DNA binding (17%), small RNA discovery
(17%), discovery of novel splice forms (13%), and DNA modification (10%).
Sixty-five percent of All Users cited RNAseq for gene expression as the application that
best suited their research objectives, followed by targeted sequencing (41%), whole genome
Table 2. Publicly available NGS datasets used for analysis (Current Users).
Dataset n (%)
TCGA 11/32 (34%)
NCBI 2/32 (6%)
SRA 2/32 (6%)
1000 Genomes 2/32 (6%)
Numerous 6/32 (19%)
Other 9/32 (28%)
Not speciﬁed 1/32 (3%)
doi:10.1371/journal.pone.0131166.t002
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sequencing (39%), and whole exome sequencing (37%) (Table 5). Fewer than 10% of investiga-
tors are not sure what applications would best suit their objectives. Investigators most fre-
quently identified sequencing by synthesis (Illumina: HiSeq or MiSeq) as the platform or
method best suited to their objectives. However, many are not educated about the plethora of
options. Despite their experience with NGS, 34% of Current Users are not sure what platform
or method would be best. Of those users, most have not investigated platform options and do
not know who to consult about platform options. Future Users are even less certain about plat-
forms and methods, with 70% not sure what best suits their objectives.
Workforce: current capacity and unmet needs
Among investigators who analyze NGS data within their laboratory, the number of lab person-
nel primarily tasked with analyzing NGS data ranged from 0 to 6. Thirty-seven percent of these
respondents report that they have a single individual primarily tasked with analyzing NGS
data. The vast majority of researchers reported having fewer than four individuals tasked with
Table 3. Reasons respondents are unable to sequence samples and analyze sequences (All Users).
Category Reason Cited by Respondent n (%)
Reason unable to sequence samples Cost/limited funds 20/31 (65%)
Resources at university 7/31 (23%)
Time/waiting for results 2/31 (6%)
Other 2/31 (6%)
Reason unable to analyze sequences Lack of Expertise 8/28 (29%)
Time 6/28 (21%)
Lack of help/support 3/28 (11%)
Lack of resources 3/28 (11%)
Funding 2/28 (7%)
Too much data 2/28 (7%)
Not complete dataset/recent acquisition of data 2/28 (7%)
Low throughput by collaborator 1/28 (4%)
Ongoing 1/28 (4%)
doi:10.1371/journal.pone.0131166.t003
Table 4. Research objectives of survey respondents (All Users).
Research Objectives n (%)
Cancer disease-speciﬁc variants, structural variation, or copy-number changes 38/104 (37%)
Non-cancer disease-speciﬁc variants, structural variation, or copy-number changes 41/104 (39%)
Population biology 8/104 (8%)
Evolutionary biology 8/104 (8%)
Metagenomics 6/104 (6%)
DNA modiﬁcation 10/104 (10%)
Protein-DNA binding 18/104 (17%)
Discovery of novel transcripts (gene discovery) 22/104 (21%)
Discovery of novel splice forms 13/104 (13%)
Small RNA discovery 18/104 (17%)
Gene expression 56/104 (54%)
Systems modeling and prediction 23/104 (22%)
Other 17/104 (16%)
doi:10.1371/journal.pone.0131166.t004
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NGS analysis, with 27% of investigators employing 2 and another 27% employing 3 lab person-
nel. Despite the existence of a nascent workforce, only 48% of respondents who are running an
NGS analysis pipeline have any staff specifically trained in bioinformatics. These trained staff
members have varying levels of education in bioinformatics (Table 6). Furthermore, 40% of
respondents with trained staff indicate that some or all of their staff are entirely self-taught.
Respondents reported that staff members had varied skills, but statistical programming and
Unix and shell scripting were identified more frequently than object oriented programming
and database development and management (Table 6). Across All Users, 26% expect to hire
new staff to assist with future NGS analysis needs. A variety of skills will be sought in new staff,
including statistical programming (74%), object oriented programming (70%), Unix and shell
scripting (65%), and database development and management (57%).
Storage methods: current capacity and unmet needs
We asked Current Users to assess their current data storage needs. Thirty-four percent of Cur-
rent Users do not have the data storage capacity to handle their current NGS data needs. In
addition, we asked All Users about future data storage needs. Only 10% felt they have the data
storage capacity to handle their future needs. Over three-quarters (76%) of respondents expect
Table 5. Applications and platforms/methods identified as best to suit objectives (All Users).
Category Applications and Platforms/Methods n (%)
Applications identiﬁed to best suit
objectives
Targeted sequencing (Ampli-Seq or Target
Seq)
43/104
(41%)
Whole exome sequencing 38/104
(37%)
Whole genome sequencing 41/104
(39%)
RNAseq for gene expression 68/104
(65%)
RNAseq for intron splice junctions (novel RNA
discovery)
14/104
(13%)
RNAseq for miRNA 28/104
(27%)
MethylSeq 22/104
(21%)
CHiPSeq 28/104
(27%)
Not sure 9/104 (9%)
Other 8/104 (8%)
Platforms/methods identiﬁed to best suit
objectives
Ion semiconductor (Ion Torrent sequencing 29/104
(28%)
Pyrosequencing (Roche 454) 13/104
(13%)
Sequencing by synthesis (Illumina: HiSeq or
MiSeq)
49/104
(47%)
Sequencing by ligation (Life SOLiD
sequencing)
7/104 (7%)
Chain termination (Sanger sequencing) 11/104
(11%)
Not sure 47/104
(45%)
Other 8/104 (8%)
doi:10.1371/journal.pone.0131166.t005
NGS Needs Assessment
PLOS ONE | DOI:10.1371/journal.pone.0131166 June 26, 2015 7 / 16
to acquire additional storage in order to meet future storage demands. Among investigators
who do not have the storage capacity to handle their current needs, 80% expect to acquire addi-
tional storage. However, there is no predominant storage method investigators expect to use,
and 26% of respondents are not sure how they will meet their future storage needs.
Table 7 illustrates current and future data storage methods. The most common storage sys-
tem was external hard drives, which 62% of respondents used. Many users also reported storing
Table 6. Characteristics of Next Generation Sequencing workforce.
Category Training and Skills n (%)
Staff members of Current Users trained in
bioinformatics: Level of education in
bioinformatics
Entirely self-taught 8/20
(40%)
Bioinformatics short course 7/20
(35%)
Masters in bioinformatics, computational
biology, computer science, or a related
ﬁeld
8/20
(40%)
PhD in bioinformatics, computational
biology, computer science, or a related
ﬁeld
10/20
(50%)
Skills one or more laboratory workers possess
(Current Users)
Unix and shell scripting 24/42
(57%)
Object oriented programming 15/42
(36%)
Database development and management 15/42
(36%)
Statistical programming 22/42
(52%)
Not sure 13/42
(31%)
Skills sought in future NGS staff (All Users) Unix and shell scripting 15/23
(65%)
Object oriented programming 16/23
(70%)
Database development and management 13/23
(57%)
Statistical programming 17/23
(74%)
Other (genetic and medical models) 1/23
(4%)
doi:10.1371/journal.pone.0131166.t006
Table 7. Current and future storagemethods for NGS data (Current Users).
Category Storage Method n (%)
Currently use External hard drive 40/65 (62%)
Servers (total) 44/65 (68%)
Servers in lab 26/65 (40%)
Servers outside lab 27/65 (42%)
Cloud storage 6/65 (9%)
Expect to use in future External hard drive 53/65 (82%)
Servers (total) 47/64 (73%)
Servers in lab 39/65 (60%)
Servers outside lab 23/64 (36%)
Cloud storage 22/65 (34%)
doi:10.1371/journal.pone.0131166.t007
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data on servers, either in their own laboratory (40%) or in other facilities (42%). Only 9% of
respondents are currently using cloud storage. In the future, respondents expect to use external
hard drives (82%) and servers within their labs (60%) at high levels. The largest projected
increase is in the use of cloud storage, which 34% of Current Users expect to use in the future.
Current and anticipated costs and funding for NGS sequencing and
analysis
Most Current Users reported that they have not allocated large amounts of funding to NGS
sequencing and analysis, but many respondents expected to increase their funding allocations in
the future (Table 8). Among Current Users, 22% had allotted no funding for performing sequencing
in the past 3 years, while only 10% allotted $100,000 or more per year. Forty-one percent of investi-
gators allotted between $10,000 and $50,000 per year during this time. In comparison, analysis and
storage of data were more commonly funded than sequencing. A greater number of researchers
apportioned funds for analyzing and storing the data, with only 18% of respondents reporting that
they had allotted no funding for the past 3 years. However, funding amounts for analyzing and
storing data were much lower, with 44% of investigators allocating less than $10,000 per year.
Respondents plan to allot more funding in the future, with 82% expecting to allocate over
$10,000 per year for sequencing over the next 3 years, compared to 62% who allotted over
$10,000 per year in the past 3 years (Table 8). Additionally, a greater proportion of NGS users
plan to allocate some funding in the future, with 91% of respondents planning to allot funding
for performing sequencing and 93% planning to allot funding for analysis and data storage
over the next 3 years.
Challenges to NGS sequencing and analysis
We asked All Users about perceived challenges to analyzing and storing sequencing data, work-
flow, and cloud computing/storage (Table 9). Each item was rated on a scale from 1 (not at all
challenging) to 5 (very challenging). All challenges were rated as somewhat difficult to overcome
Table 8. Funding allotted per year for Next Generation Sequencing (Current Users).
Category Funding n (%) Past 3
Years
n (%) Next 3
Years
Funding allotted per year for performing
sequencing
None 15/68 (22%) 6/68 (9%)
Less than
$10,000
11/68 (16%) 6/68 (9%)
$10,000-$49,999 28/68 (41%) 35/68 (51%)
$50,000-$99,999 7/68 (10%) 13/68 (19%)
$100,000-
$250,000
5/68 (7%) 6/68 (9%)
More than
$250,000
2/68 (3%) 2/68 (3%)
Funding allotted per year for analyzing and
storing data
None 12/68 (18%) 5/68 (7%)
Less than
$10,000
30/68 (44%) 22/68 (32%)
$10,000-$49,999 16/68 (24%) 22/38 (32%)
$50,000-$99,999 5/68 (7%) 7/68 (10%)
$100,000-
$250,000
3/68 (4%) 10/68 (15%)
More than
$250,000
2/68 (3%) 2/68 (3%)
doi:10.1371/journal.pone.0131166.t008
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on average. Respondents (n = 77) perceived that sample preparation or library construction was
the easiest task, with an average difficulty of 2.4. The two most challenging tasks were finding a
person to perform the analysis (3.6) and how to meet the cost (3.7). Almost all items in the ana-
lyzing and storing sequencing data category were rated above average difficulty (3). This indicates
that there are hurdles to overcome in all categories, but that they are not insurmountable.
Knowledge among investigators who are not planning to use NGS
A total of 29 respondents are neither currently using nor planning to use NGS data (Non
Users). Among these investigators, 38% have research questions that next generation sequenc-
ing can answer. Among respondents who have research questions that NGS can answer, 30%
of respondents have investigated options for sequencing. Only 10% of these respondents know
what technologies, methods, or platforms to use, but 78% report that they know where to find
help to make decisions about which methods, technologies, or platforms to use. However, no
respondents have investigated options for analysis or know what analysis software to use.
Discussion
Advances in high throughput sequencing are fundamentally changing biomedical research and
patient care–supporting a new paradigm of personalized medicine that includes genomic
Table 9. Challenges to use of Next Generation Sequencing (All Users).
Category Challenges Average
Difﬁculty
Challenges to analyzing and storing
sequencing data
Cost 3.7
Finding a person to perform the analysis 3.6
Access to computing power to perform
the analysis
3.4
Rapidly changing tools 3.3
Management of the data 3.2
Availability of storage space 3.2
Lack of standardization of data formats 3.1
Data transfer (networking) 3.1
Difﬁculty of using open source software 3.1
Compliance with regulations and policies 2.8
Access control/security 2.7
Other 1.0
Challenges to workﬂow Data analysis and construction 3.5
Moving the data along the workﬂow 3.1
Storage 3.0
Sharing the data with collaborators 2.7
Sequencing 2.6
Sample prep or library construction 2.4
Challenges to use of cloud computing/
storage
Data transfer issues 3.4
Cost 3.3
Security 3.2
Knowledge 3.2
Availability 3.0
Not advanced enough 2.9
Other 2.3
doi:10.1371/journal.pone.0131166.t009
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analysis as part of diagnostic and therapeutic decision-making [5, 6]. Although it provides sig-
nificant promise, the ‘path to personalized medicine’ [7] is also likely to produce significant
changes in the needs of the research community. Despite this emerging challenge, few road-
maps exist to help academic medical centers anticipate and plan for changing needs in this
field. Following the establishment of the Institute for Personalized Medicine (IPM) at Univer-
sity of Pittsburgh, we undertook a systematic analysis of the data management needs of health
sciences investigators who are either using or planning to use NGS methods. As a leading
research institution (currently ranked 5th in NIH funding) associated with a large vertically-
integrated health care system (UPMC), this needs assessment provides an in-depth case study
which may be of use to other AMCs as they identify and plan for future needs.
This discussion is organized around a set of key principles emerging from our survey, pri-
marily focused on development of appropriate IT infrastructure, support of analytical
resources, and education. Using these principles, our institution has launched specific initia-
tives designed to enhance our maturing ability to support the use of next generation sequencing
for translational sciences. For each principle, we provide examples from our efforts, as well as
limitations and pitfalls for development within this rapidly changing environment.
1. Cultivate strategic partnerships with research computing groups
within the organization
The scale of NGS presents data management challenges not previously encountered by many
institutions [31–33]. As AMCs develop information architectures, centers of expertise, and
human processes to support personalized medicine initiatives, they can anticipate further
strain on core resources [21]. Institutional support for data management will likely require
partnerships that extend beyond traditional AMC boundaries, such as partnerships with indus-
try and scientific computing centers. Forging such partnerships may be an important early step
in program development.
An important early step at our institution was the development of a campus-wide strategic
task force designed to specifically address the institutional aspects of managing this transition.
In an effort to directly address the infrastructure needs elicited from participants, the Task
Force and the Institute for Personalized Medicine assisted the Schools of the Health Sciences at
University of Pittsburgh in developing strategic partnerships, both internally and externally.
The Pittsburgh Supercomputing Center (PSC) [34] now hosts more than one petabyte of Pitt/
UPMC NGS data on PSC’s proprietary Data Exacell parallel file system [35]–a set of high per-
formance software and hardware building blocks for scientific computing, which is funded by
the National Science Foundation. At the same time, we have significantly invested in the Uni-
versity Simulation and Modeling Center (SaM)[36], a centralized research computing group
supporting several large-scale computing clusters. SaM provides high-quality, investigator-
focused software and hardware resources, as well as consultants to assist researchers in moving
their analysis pipelines to a clustered computing environment. These strategic partnerships
have provided researchers using NGS methods at our University with access to significant stor-
age and computational resources.
2. Build for high-throughput as well as high-performance computing
needs
Results from our survey suggested a wide array of research objectives that require diverse
computational infrastructures. High Performance Computing (HPC) environments provide
parallel computing with infrastructures built for capability over capacity. In these types of envi-
ronments, jobs typically require many hundreds or even thousands of CPUs, and potentially
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many gigabytes or even terabytes of memory, but very little storage. Job components need to
communicate with one another over the entire set of CPUs. Under these conditions, large
shared memory, message-passing interfaces, and low latency interconnects are essential for
some important NGS computational tasks such as denovo RNA and DNA assembly. However,
for most NGS computational tasks, the processing capacity may outweigh capability. In these
situations, High Throughput Computing (HTC) architectures are typically preferred, allowing
distribution of many thousands of jobs with low CPU requirements, and little to no inter-pro-
cess communication, but much larger storage requirements. Bioinformatics pipelines can often
be efficiently deployed in such HTC environments. As we develop our partnerships with the
Simulation Modeling Center (SaM) and the Pittsburgh Supercomputing Center, which use
both HPC and HTC environments, we are refining our understanding of how to use each set of
resources to its best advantage, and how to best direct researchers to the appropriate resources
for their work.
3. Develop centralized NGS data management as well as analysis
Centralized computing resources such as PSC and SaM provide important physical infrastruc-
ture including compute nodes, storage, networking, security, and support for managing the
regulatory compliance aspects needed for NGS research [37]. But actual management of NGS
data requires an investment beyond such physical infrastructure, including support for data
provenance, integration, processing, and analysis. Specific centralized data management efforts
can increase efficiency and reduce barriers to entry for investigators who are starting to use
NGS in their labs. An advantage of centralizing data management infrastructure is that a
diverse array of technologies can be employed to tier data based on the frequency with which
the data must be accessed. Centralized infrastructure can also stage data between locations in
advance of the movement to specific locations as part of the analysis workflow.
As an example, our survey showed that a large number of investigators were either currently
using or interested in using TCGA data [38]. Consequently, we developed a process to auto-
matically download, version, store, and update TCGA data (including BAM files) at the Pitts-
burgh Supercomputing Center, and to use the PSC distributed file system to make these same
files available at the Simulation and Modeling Center. The process enables resources from both
centers to be used with TCGA data. The Pittsburgh Genome Resource Repository (PGRR) sup-
ports a multi-investigator collaborative effort to use multi-institutional datasets such as TCGA
for NGS analysis and personalized medicine. Collocating such large NGS datasets with relevant
tools and compute resources at two research computing units has greatly enhanced the avail-
ability and utility of this dataset to our research community.
4. Anticipate future use of cloud-computing, while recognizing its
limitations
Cloud-based storage and analysis are increasingly popular for NGS data [39], because of the
relative flexibility, scalability, and affordability [22, 40–42]. Genomics cloud computing provid-
ers, such as Globus Genomics, Google Genomics, and Amazon Web Services, offer services
using a variety of models and pipelines. More specific cloud-based bioinformatics workflow
platforms provide further capabilities [43, 44]. These resources offer significant advantages for
some NGS analysis use cases [24], particularly for researchers who have a single set of samples
to examine. In contrast, for projects which are constantly accruing participants, or for ongoing
efforts such as those envisioned in a personalized medicine setting, long-term storage of large
data sets and repeated re-analysis of data make in-house computing resources far more cost
effective than cloud providers. For investigators working with dbGAP datasets, Data Use
NGS Needs Assessment
PLOS ONE | DOI:10.1371/journal.pone.0131166 June 26, 2015 12 / 16
Terms previously restricted use of cloud providers for protected data. But recent shifts in NIH
policy [45], aligned with early experiments in NIH cloud-based resources, are significantly
changing the landscape. Investigators in our institution are already using cloud resources for
their own NGS projects, and we are beginning to consider how to leverage cloud providers
through capabilities such as “cloud-bursting” (offloading jobs from overloaded computing
resources in our institution to cloud providers on an as-needed basis). At the same time, many
AMCs remain concerned about the wholesale use of cloud computing providers for sequencing
data. Although research NGS data does not technically meet the definition of Protected Health
Information, it is nonetheless sensitive personal information, incurring risk for re-identifica-
tion or misuse [46]. New HIPAA-compliant cloud resources should help to alleviate these con-
cerns, but will also require more significant investment for their use.
5. Consider institution-wide sequencing capacity and plan for
sustainable growth
As shown in this survey, sequencing is an important bottleneck for NGS data processing. In
our institutions, investigators are meeting their sequencing needs through a wide range of
methods, from core resources to commercial providers. Choices are often specific to the needs
of individual projects. Researchers may require an array of other services, from sample prepa-
ration to analysis and storage, as well as expertise in interpretation. Access to sequencing
resources is becoming increasingly routine, and even amenable to “comparison shopping”
through marketplace applications such as GenoHub [47]. In many respects, the key barrier is
now cost. With a tightened NIH budget, traditional sources of funding are greatly reduced.
Pilot programs such as those offered locally through Cancer Center Support Grants and Clini-
cal and Translational Sciences Awards can provide vital seed funding for investigators to accrue
preliminary data for grant applications. However, a more cohesive and long term strategy is
needed to develop a sustainable model for funding NGS data generation. This could include
negotiating larger volume contracts at reduced price and/or enhanced service, or explicitly
funneling low complexity projects to commodity resources. Institutions that address these
problems early on may benefit as demand increases.
6. Develop core analytic groups with financial model for escalating
needs
NGS analysis requires specialized expertise that blends biological, statistical, computational,
and communication skills [48]. AMCs can anticipate the need for more analytic capabilities as
demand increases. While researchers can be expected to contribute to the costs of these core
analytic groups, it is impractical to expect that all operational costs can be absorbed by the proj-
ects themselves. Using a cost-sharing model where a portion of the support for core analytical
groups is provided by the University and a portion is shouldered by the investigators, we have
increased our analytic capabilities significantly. As investigators request analytic help from our
Bioinformatics Core Service, we apportion analysis time and hire new analysts as workloads
increase. Institutional resources help cover intervals with lighter workloads, and enable hiring
of new analysts before they reach 100% salary coverage.
7. Invest in bioinformatics training at all levels
Significant educational needs were identified in this rapidly changing domain. Individuals cur-
rently tasked with analyzing NGS data in individual labs often have very limited training in
bioinformatics. To meet these immediate needs, workshops and other short-term
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programming for laboratory staff engaged in NGS analysis can provide an immediate way to
address educational gaps. At our institution, an intensive three week summer NGS workshop run
by one of our authors (MB) provides hands-on training in NGS analysis using datasets, tools, and
infrastructures available at our institution. Over 250 individuals have attended this workshop in
the last three years. This program fills a critical niche for training staff, students, and postdocs
who are working with NGS data. An advantage of a workshop run within the institution is that it
fosters development of a community among analysts in the research labs, and between these indi-
viduals and the analysts in the bioinformatics core services. Institutions also need to further invest
in NGS by addressing educational gaps with long-term strategies, such as developing, sustaining,
and expanding formal bioinformatics undergraduate and graduate programs. As a result of this
survey and current trends in genomics and bioinformatics, we are expanding several existing
graduate training programs and are partnering with other departments such as Computer Science
and Information Science to develop innovative new training programs. Looking forward, federal
support for programs that seek to retrain qualified bioscience PhDs and postdoctoral trainees
may also help establish a larger bioinformatics workforce.
Conclusions
This study provides an in-depth analysis of the current and planned use of NGS data analysis for
health sciences research at a single academic medical center. Our findings suggest significant insti-
tutional challenges that AMCs can address to enhance their capacity for growth in genomic medi-
cine, including infrastructure issues, support for centralized analytic resources, and education.
Key principles for change management in this rapidly evolving space are presented. Based on
these principles, our institution has taken initial steps towards development of Big Data infra-
structure. Early strategic planning by AMCs will help to prevent the development of individually-
targeted solutions, which may produce considerable fractionation of resources and duplication of
services. Development of a campus-wide task force to address infrastructure and analytic issues is
recommended to ensure that all members of the community benefit from the proposed changes.
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